title: Type 2 diabetes, thiazolidinediones: bad to the bone?
authors.forename: Nelson B
authors.initials: NB
authors.lastname: Watts
authors.forename: David A
authors.initials: DA
authors.lastname: D'Alessio
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D015519:Bone Density / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced*; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones